Completed NA INTERVENTIONAL 2-arm NCT03494036

Effect of Synbiotic on Immune Response, Gut Permeability and Microbiota in Patient With Connective Tissue Disease

Effect of Synbiotic Supplementation on Interleukin 17 (IL-17) Level, Regulatory T-cells, Gut Permeability and Microbiota in Patient With Connective Tissue Disease

Sponsor: Fakultas Kedokteran Universitas Indonesia

Conditions Connective Tissue Diseases

Interventions Placebo Synbiotic

Updated 6 times since 2018 Last updated: Mar 10, 2019 Started: Oct 1, 2017 Primary completion: Jul 31, 2018 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03494036, this NA trial focuses on Connective Tissue Diseases and remains completed. Sponsored by Fakultas Kedokteran Universitas Indonesia, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2018 — Apr 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

May 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fakultas Kedokteran Universitas Indonesia

Data source: Fakultas Kedokteran Universitas Indonesia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia